Carnexiv FDA Approval History
Marketing Status: Discontinued
Carnexiv (carbamazepine) is an intravenous injection formulation of the antiepileptic drug carbamazepine indicated as short-term replacement therapy for oral carbamazepine when oral administration is temporarily not feasible.
Development Timeline for Carnexiv
|Oct 7, 2016||FDA Approves Carnexiv (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types|
|Apr 22, 2016||FDA Accepts Lundbeck Resubmission of New Drug Application for Carnexiv (carbamazepine)|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.